NanoViricides Inc Share Price OTC Bulletin Board
Equities
US6300871042
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 21.2M 1.67B |
---|---|---|---|---|---|
Net income 2024 * | -8M -631M | Net income 2025 * | -14M -1.1B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.47
x | P/E ratio 2025 * |
-1.62
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.68% |
Managers | Title | Age | Since |
---|---|---|---|
Anil Diwan
CEO | Chief Executive Officer | 66 | 31/03/05 |
Meeta Vyas
DFI | Director of Finance/CFO | 66 | 12/05/13 |
Jayant Tatake
CTO | Chief Tech/Sci/R&D Officer | - | 02/03/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Zucker
BRD | Director/Board Member | 62 | 12/11/20 |
Anil Diwan
CEO | Chief Executive Officer | 66 | 31/03/05 |
Director/Board Member | 73 | 06/02/20 |
1st Jan change | Capi. | |
---|---|---|
+7.52% | 113B | |
+11.38% | 106B | |
+0.82% | 22.27B | |
-12.64% | 22.22B | |
-4.55% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |